Cargando…
Evaluation of [Cys(ATTO 488)(8)]Dermorphin-NH(2) as a novel tool for the study of μ-opioid peptide receptors
The μ-opioid peptide (MOP) receptor is a member of the opioid receptor family and an important clinical target for analgesia. Measuring MOP receptor location and tracking its turnover traditionally used radiolabels or antibodies with attendant problems of utility of radiolabels in whole cells and po...
Autores principales: | Giakomidi, Despina, Bird, Mark F., McDonald, John, Marzola, Erika, Guerrini, Remo, Chanoch, Serena, Sabu, Nidhuna, Horley, Barbara, Calo, Girolamo, Lambert, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064508/ https://www.ncbi.nlm.nih.gov/pubmed/33891604 http://dx.doi.org/10.1371/journal.pone.0250011 |
Ejemplares similares
-
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)
por: Bird, Mark F., et al.
Publicado: (2016) -
Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor
por: Bird, M F, et al.
Publicado: (2018) -
Atto488-Agitoxin 2—A Fluorescent Ligand with Increased Selectivity for Kv1.3 Channel Binding Site
por: Denisova, Kristina R., et al.
Publicado: (2022) -
Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuli
por: Giakomidi, Despina, et al.
Publicado: (2022) -
Biased Agonism at Nociceptin/Orphanin FQ Receptors:
A Structure Activity Study on N/OFQ(1–13)-NH(2)
por: Pacifico, Salvatore, et al.
Publicado: (2020)